LDC000067 CAS：1073485-20-7

LDC000067 is a potent and selective CDK9 inhibitor.LDC000067 inhibited in vitro transcription in an ATP-competitive and dose-dependent manner.Gene expression profiling of cells treated with LDC000067 demonstrated a selective reduction of short-lived mRNAs,including important regulators of proliferation and apoptosis. Analysis of de novo RNA synthesis suggested a wide ranging positive role of CDK9.At the molecular and cellular level,LDC000067 reproduced effects characteristic of CDK9 inhibition such as enhanced pausing of RNA polymerase II on genes and, most importantly,induction of apoptosis in cancer cells.LDC000067 inhibits P-TEFb-dependent in vitro transcription.Induces apoptosis in vitro and in vivo in combination with BI 894999.

msds---LDC000067